This product is for research use only, not for human use. We do not sell to patients.
Size | Price | Stock |
---|---|---|
5mg | $400 | To Be Confirmed |
10mg | $600 | To Be Confirmed |
25mg | $1150 | To Be Confirmed |
50mg | $1700 | To Be Confirmed |
Cat #: V29257 CAS #: 1034442-21-1 Purity ≥ 99%
Description: Basimglurant (RG7090; RO491752) is a potent, selective and orally bioavailable mGlu5 negative allosteric modulator with a Kd of 1.1 nM. It is under Phase 2 clinical trial for treating MDD and Fragile X syndrome (FXS). Basimglurant is a promising novel medicine for psychiatric diseases. Basimglurant has favorable drug-like properties, a differentiated molecular mechanism of action, and antidepressant-like features which suggest the possibility of also addressing important comorbidities of MDD including anxiety and pain as well as daytime sleepiness and apathy or lethargy.
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
Molecular Formula | C₁₈H₁₃ClFN₃ |
---|---|
CAS No. | 1034442-21-1 |
SMILES Code | CC1=C(C#CC2=CC(Cl)=NC=C2)N=C(C)N1C3=CC=C(F)C=C3 |
Synonyms | RG-7090; RG 7090; RG7090; RO4917523; RO 4917523; RO-4917523; CTEP Derivative |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.